Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.66 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.66 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | CD69 | Q07108 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.51 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.50 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.50 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.48 |
| ▸ | AMY2A | P04746 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466466 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL117333 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL30055416 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL9398176 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL10524839 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL14268473 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL4309100 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17050874 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL4125477 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL20555908 | 1.00 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510520-A | Pharmaceutical composition of mycophenolic acid and/or betamethasone for the treatment of ocular diseases | 瑟菲斯眼科股份有限公司 | 2024-08-16 | — | — | CN | disclosed |
| US-20240192235-A1 | CERAMIDE AND SPINGOMYELIN IN NEUROLOGICAL DISORDERS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-06-13 | — | — | US | disclosed |
| CN-116334113-A | Conditionally active heterodimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022226427-A2 | CERAMIDE AND SPHINGOMYELIN IN NEUROLOGICAL DISORDERS | DUKE UNIVERSITY (US) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022226280-A1 | CERAMIDE AND SPINGOMYELIN IN NEUROLOGICAL DISORDERS | DUKE UNIVERSITY (US) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022221559-A2 | CERAMIDE AND SPHINGOMYELIN IN NEUROLOGICAL DISORDERS | DUKE UNIVERSITY (US) | 2022-10-20 | — | — | WO | disclosed |